Global Psoriasis Market Drivers 2024, Forecast To 2033
18 Jan, 2024
The psoriasis market demonstrated robust growth, rising from $23.87 billion in 2023 to $26.5 billion in 2024, with an 11.0% CAGR. The historical growth owes itself to factors like epidemiology awareness and healthcare infrastructure. Predictions for 2028 estimate a market size of $39.17 billion, propelled by regulatory approvals, patient preferences, and novel therapies. Emerging trends in the forecast period include research advancements, biologics, telemedicine, and digital health, emphasizing a patient-centric approach.
Global Psoriasis Market Key Driver
Psoriasis market growth stems from an increased prevalence linked to factors like climate change and stress. Approximately 125 million people, 2-3% of the global population, suffer from psoriasis. This rise fuels expectations for psoriasis market growth over the forecast period.
Get A Free Sample Of The Global Psoriasis Market ReportGlobal Psoriasis Market Segments
The psoriasis market covered in this report is segmented –
1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
By Geography: The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the psoriasis market in 2023. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Psoriasis Industry Players
AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy
Get The Full Global Psoriasis Market Report
Psoriasis Market Overview
Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells.
Psoriasis Global Market Report 2023 provides data on the global psoriasis market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The psoriasis market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.